======= VAPA ======= == Gene Information == * **Official Symbol**: VAPA * **Official Name**: VAMP associated protein A * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9218|9218]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9P0L0|Q9P0L0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=VAPA&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20VAPA|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605703|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Binds to OSBPL3, which mediates recruitment of VAPA to plasma membrane sites (PubMed:25447204). The ORP3-VAPA complex stimulates RRAS signaling which in turn attenuates integrin beta-1 (ITGB1) activation at the cell surface (PubMed:25447204). With OSBPL3, may regulate ER morphology (PubMed:16143324). May play a role in vesicle trafficking (PubMed:11511104, PubMed:19289470). {ECO:0000269|PubMed:11511104, ECO:0000269|PubMed:16143324, ECO:0000269|PubMed:19289470, ECO:0000269|PubMed:25447204}. |Motile Sperm| |FFAT motif binding| |positive regulation by host of viral release from host cell| |modulation by host of viral release from host cell| |negative regulation by host of viral genome replication| |positive regulation by host of viral genome replication| |negative regulation by host of viral process| |modulation by host of viral genome replication| |positive regulation of viral release from host cell| |positive regulation by host of viral process| |protein folding in endoplasmic reticulum| |modulation by host of viral process| |endoplasmic reticulum exit site| |regulation of viral release from host cell| |positive regulation of viral genome replication| |endoplasmic reticulum organization| |negative regulation of viral genome replication| |azurophil granule membrane| |positive regulation of viral life cycle| |COPII-coated vesicle budding| |modification by host of symbiont morphology or physiology| |interaction with symbiont| |Golgi vesicle budding| |negative regulation of viral life cycle| |sphingolipid biosynthetic process| |regulation of viral genome replication| |vesicle budding from membrane| |negative regulation of viral process| |positive regulation of viral process| |modification of morphology or physiology of other organism involved in symbiotic interaction| |bicellular tight junction| |membrane lipid biosynthetic process| |membrane fusion| |protein localization to endoplasmic reticulum| |vesicle| |regulation of viral life cycle| |microtubule cytoskeleton| |sphingolipid metabolic process| |modification of morphology or physiology of other organism| |positive regulation of I-kappaB kinase/NF-kappaB signaling| |membrane lipid metabolic process| |regulation of viral process| |endoplasmic reticulum to Golgi vesicle-mediated transport| |negative regulation of multi-organism process| |regulation of symbiosis, encompassing mutualism through parasitism| |protein folding| |regulation of I-kappaB kinase/NF-kappaB signaling| |nuclear membrane| |microtubule binding| |protein domain specific binding| |vesicle organization| |cadherin binding| |Golgi vesicle transport| |endomembrane system organization| |neutrophil degranulation| |protein heterodimerization activity| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |positive regulation of multi-organism process| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |positive regulation of locomotion| |lipid biosynthetic process| |myeloid leukocyte activation| |Golgi membrane| |leukocyte activation involved in immune response| |cell activation involved in immune response| |neuron projection development| |perinuclear region of cytoplasm| |regulated exocytosis| |protein localization to organelle| |leukocyte mediated immunity| |regulation of multi-organism process| |symbiotic process| |exocytosis| |neuron development| |interspecies interaction between organisms| |membrane organization| |leukocyte activation| |endoplasmic reticulum membrane| |cellular lipid metabolic process| |regulation of locomotion| |secretion by cell| |neuron differentiation| |endoplasmic reticulum| |positive regulation of intracellular signal transduction| |export from cell| |cell activation| |immune effector process| |cell death| |secretion| |plasma membrane bounded cell projection organization| |cell projection organization| |lipid metabolic process| |organonitrogen compound biosynthetic process| |intracellular transport| |generation of neurons| |cellular protein localization| |cellular macromolecule localization| |neurogenesis| |cell development| |positive regulation of signal transduction| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |establishment of localization in cell| |immune response| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-2.79| |[[:results:exp348|Cyclosporin-A 3μM R07 exp348]]|-2.06| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|-2.06| |[[:results:exp169|BH1 1μM R04 exp169]]|-1.93| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|-1.91| |[[:results:exp444|THZ531 0.225μM R08 exp444]]|-1.91| |[[:results:exp530|Thioridazine 5μM R08 exp530]]|-1.9| |[[:results:exp452|Azithromycin 100μM R08 exp452]]|-1.88| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|-1.77| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|1.73| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|1.8| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|1.81| |[[:results:exp433|LJH685 50μM R08 exp433]]|1.81| |[[:results:exp264|Arsenate 40μM R06 exp264]]|1.84| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|2.15| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|2.3| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|2.51| ^Gene^Correlation^ |[[:human genes:m:mbtps1|MBTPS1]]|0.464| |[[:human genes:s:scap|SCAP]]|0.421| |[[:human genes:m:mbtps2|MBTPS2]]|0.419| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3985 * **Expression level (log2 read counts)**: 6.73 {{:chemogenomics:nalm6 dist.png?nolink |}}